Alector, Inc. Common Stock
€1.911
EUR
Last updated on --.
24h volume425.03K
24h highest1.9633 EUR
24h lowest1.8813 EUR
24h Price movement+1.14%
ALEC recent prices
24 Hours
+1.14%+€0.021575
30 days
-7.32%-€0.15103
60 days
+9.65%+€0.16829
90 days
-8.85%-€0.18555
Key data
Previous close1.8900 EUR
Market cap203.13M EUR
Volume425.03K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.97519 EUR
Net income (FY)-108.21M EUR
Revenue (FY)15.89M EUR
Last report dateMay 7, 2026
About Alector, Inc. Common Stock
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)103.00
Revenue per employee (FY)154.31K EUR
Net income per employee (FY)-1.05M EUR
Listed onNasdaq
ALEC conversion tables
 |  |
|---|---|
| 0.5 ALEC | 0.95577 EUR |
| 1 ALEC | 1.911 EUR |
| 5 ALEC | 9.557 EUR |
| 10 ALEC | 19.11 EUR |
| |
|---|---|
| 0.5 EUR | 0.26157 ALEC |
| 1 EUR | 0.52314 ALEC |
| 5 EUR | 2.615 ALEC |
| 10 EUR | 5.231 ALEC |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ALEC is trading at €1.911, +1.14% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ALEC stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ALEC is currently trading at €1.911, +1.14% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ALEC price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ALEC's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ALEC; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ALEC's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Alector, Inc. Common Stock's market cap is currently 203.13M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume425.03K
24h highest1.9633 EUR
24h lowest1.8813 EUR
24h Price movement+1.14%
Start trade with ALEC Perpetual
Sign up to trade